{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:16:19Z","timestamp":1789535779251,"version":"build-2803163510"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetes mellitus is characterized by the body\u2019s inability to control blood glucose levels within a physiological range due to loss and\/or dysfunction of insulin producing beta cells. Progressive beta cell loss leads to hyperglycemia and if untreated can lead to severe complications and\/or death. Treatments at this time are limited to pharmacologic therapies, including exogenous insulin or oral\/injectable agents that improve insulin sensitivity or augment endogenous insulin secretion. Cell transplantation can restore physiologic endogenous insulin production and minimize hyper- and hypoglycemic excursions. Islet isolation procedures and management of transplant recipients have advanced over the last several decades; both tight glycemic control and insulin independence are achievable. Research has been conducted in isolating islets, monitoring islet function, and mitigating the immune response. However, this procedure is still only performed in a small minority of patients. One major barrier is the scarcity of human pancreatic islet donors, variation in donor pancreas quality, and variability in islet isolation success. Advances have been made in generation of glucose responsive human stem cell derived beta cells (sBCs) and islets from human pluripotent stem cells using directed differentiation. This is an emerging promising treatment for patients with diabetes because they could potentially serve as an unlimited source of functional, glucose-responsive beta cells. Challenges exist in their generation including long term survival of grafts, safety of transplantation, and protection from the immune response. This review focuses on the progress made in islet allo- and auto transplantation and how these advances may be extrapolated to the sBC context.<\/jats:p>","DOI":"10.3389\/fendo.2021.636824","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T09:24:42Z","timestamp":1615454682000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes"],"prefix":"10.3389","volume":"12","author":[{"given":"Taylor M.","family":"Triolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melena D.","family":"Bellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0930","article-title":"Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT\/EDIC","volume":"64","author":"Lachin","year":"2015","journal-title":"Diabetes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1215228","article-title":"Mechanisms of hypoglycemia-associated autonomic failure in diabetes","volume":"369","author":"Cryer","year":"2013","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJMx190033","article-title":"An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes","volume":"382","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999-2010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.19.4.0336","article-title":"Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects","volume":"19","author":"Ferrannini","year":"1998","journal-title":"Endocr Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2086-7","article-title":"beta-Cell dysfunction in chronic pancreatitis","volume":"57","author":"Sasikala","year":"2012","journal-title":"Dig Dis Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2337\/diab.38.1.S82","article-title":"Islet cell autoimmunity in type I diabetic patients after HLA-mismatched pancreas transplantation","volume":"38","author":"Bosi","year":"1989","journal-title":"Diabetes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.2.218","article-title":"Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes","volume":"49","author":"Braghi","year":"2000","journal-title":"Diabetes"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0498","article-title":"Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells","volume":"59","author":"Vendrame","year":"2010","journal-title":"Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.39.4.515","article-title":"Insulin independence after islet transplantation into type I diabetic patient","volume":"39","author":"Scharp","year":"1990","journal-title":"Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03977.x","article-title":"Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes","volume":"12","author":"Bellin","year":"2012","journal-title":"Am J Transplant"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.4.955","article-title":"Assessment of the Severity of Hypoglycemia and Glycemic Lability in Type 1 Diabetic Subjects Undergoing Islet Transplantation","volume":"53","author":"Ryan","year":"2004","journal-title":"Diabetes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01573.x","article-title":"Changes in renal function after clinical islet transplantation: four-year observational study","volume":"7","author":"Senior","year":"2007","journal-title":"Am J Transplant"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.4.710","article-title":"Clinical Outcomes and Insulin Secretion After Islet Transplantation With the Edmonton Protocol","volume":"50","author":"Ryan","year":"2001","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2435","DOI":"10.1371\/journal.pone.0002435","article-title":"Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation","volume":"3","author":"Huurman","year":"2008","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03812.x","article-title":"Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation","volume":"156","author":"Roelen","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-014-0627-6","article-title":"Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience","volume":"51","author":"Qi","year":"2014","journal-title":"Acta Diabetol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14323","article-title":"Deciphering Tacrolimus-Induced Toxicity in Pancreatic \u03b2 Cells","volume":"17","author":"Tri\u00f1anes","year":"2017","journal-title":"Am J Transplant"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0802893","article-title":"Widespread amyloid deposition in transplanted human pancreatic islets","volume":"359","author":"Westermark","year":"2008","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ajt.16406","article-title":"Neither amyloid depositions nor hepatic steatosis are associated with marginal islet mass early after autotransplantation","author":"Generette","year":"2020","journal-title":"Am J Transplant"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002416","article-title":"Islet Allotransplantation in the Bone Marrow of Patients With Type 1 Diabetes: A Pilot Randomized Trial","volume":"103","author":"Maffi","year":"2019","journal-title":"Transplantation"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201803_14588","article-title":"Intramuscular islet allotransplantation in type 1 diabetes mellitus","volume":"22","author":"Bertuzzi","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1613959","article-title":"Bioengineering of an Intraabdominal Endocrine Pancreas","volume":"376","author":"Baidal","year":"2017","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14642","article-title":"Transplantation of macroencapsulated human islets within the bioartificial pancreas \u03b2Air to patients with type 1 diabetes mellitus","volume":"18","author":"Carlsson","year":"2018","journal-title":"Am J Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01777.x","article-title":"Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation","volume":"7","author":"Campbell","year":"2007","journal-title":"Am J Transplant"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1258","article-title":"Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes","volume":"62","author":"Piemonti","year":"2013","journal-title":"Diabetes"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000226161.82581.b2","article-title":"A significant role for histocompatibility in human islet transplantation","volume":"82","author":"Mohanakumar","year":"2006","journal-title":"Transplantation"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(97)00327-8","article-title":"Sensitization to HLA antigens in islet recipients with failing transplants","volume":"29","author":"Olack","year":"1997","journal-title":"Transplant Proc"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0160","article-title":"Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients","volume":"58","author":"Hilbrands","year":"2009","journal-title":"Diabetes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2008.03.459","article-title":"Recurrence of autoreactive antigen-specific CD4+ T cells in autoimmune diabetes after pancreas transplantation","volume":"128","author":"Laughlin","year":"2008","journal-title":"Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35197","article-title":"Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells","volume":"118","author":"Monti","year":"2008","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3779-1","article-title":"Innate and adaptive immunity to human beta cell lines: implications for beta cell therapy","volume":"59","author":"van der Torren","year":"2016","journal-title":"Diabetologia"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508621102","article-title":"Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes","volume":"102","author":"Pinkse","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.05.012","article-title":"Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers","volume":"37","author":"Unger","year":"2011","journal-title":"J Autoimmun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00125-008-1237-z","article-title":"Accumulation of autoreactive effector T cells and allo-specific regulatory T cells in the pancreas allograft of a type 1 diabetic recipient","volume":"52","author":"Velthuis","year":"2009","journal-title":"Diabetologia"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1486","article-title":"Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers","volume":"59","author":"Velthuis","year":"2010","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000458","article-title":"Total pancreatectomy and islet autotransplantion for chronic and recurrent acute pancreatitis","volume":"34","author":"McEachron","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jamcollsurg.2011.12.040","article-title":"Total pancreatectomy and islet autotransplantation for chronic pancreatitis","volume":"214","author":"Sutherland","year":"2012","journal-title":"J Am Coll Surg"},{"key":"B42","article-title":"Human islet autotransplantation following pancreatectomy","volume":"11","author":"Najarian","year":"1979","journal-title":"Transplant Proc"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2017.12.018","article-title":"Patient Selection for Total Pancreatectomy with Islet Autotransplantation in the Surgical Management of Chronic Pancreatitis","volume":"226","author":"Morgan","year":"2018","journal-title":"J Am Coll Surg"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000920","article-title":"Long-Term Outcomes After Total Pancreatectomy and Islet Cell Autotransplantation: Is It a Durable Operation","volume":"260","author":"Wilson","year":"2014","journal-title":"Ann Surg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPA.0b013e3181825c00","article-title":"Total pancreatectomy with and without islet cell transplantation for chronic pancreatitis: a series of 85 consecutive patients","volume":"38","author":"Garcea","year":"2009","journal-title":"Pancreas"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-015-2828-x","article-title":"Effect of the Duration of Chronic Pancreatitis on Pancreas Islet Yield and Metabolic Outcome Following Islet Autotransplantation","volume":"19","author":"Takita","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001453","article-title":"Factors Predicting Outcomes After a Total Pancreatectomy and Islet Autotransplantation Lessons Learned From Over 500 Cases","volume":"262","author":"Chinnakotla","year":"2015","journal-title":"Ann Surg"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2952","article-title":"Glycemic Predictors of Insulin Independence After Total Pancreatectomy With Islet Autotransplantation","volume":"102","author":"Quartuccio","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000792","article-title":"Islet Cell Yield Following Remote Total Pancreatectomy With Islet Autotransplant is Independent of Cold Ischemia Time","volume":"46","author":"Kesseli","year":"2017","journal-title":"Pancreas"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2018.12.019","article-title":"How Durable Is Total Pancreatectomy and Intraportal Islet Cell Transplantation for Treatment of Chronic Pancreatitis","volume":"228","author":"Bellin","year":"2019","journal-title":"J Am Coll Surg"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-011-0315-8","article-title":"Deterioration of glycemic control after corticosteroid administration in islet autotransplant recipients: a cautionary tale","volume":"51","author":"Ngo","year":"2014","journal-title":"Acta Diabetol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-011-0306-9","article-title":"Severely fibrotic pancreases from young patients with chronic pancreatitis: evidence for a ductal origin of islet neogenesis","volume":"50","author":"Soltani","year":"2013","journal-title":"Acta Diabetol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsr040330","article-title":"Derivation of Embryonic Stem-Cell Lines from Human Blastocysts","volume":"350","author":"Cowan","year":"2004","journal-title":"N Engl J Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1163","article-title":"Efficient differentiation of human embryonic stem cells to definitive endoderm","volume":"23","author":"D\u2019Amour","year":"2005","journal-title":"Nat Biotechnol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1393","article-title":"Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo","volume":"26","author":"Kroon","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1259","article-title":"Production of pancreatic hormone\u2013expressing endocrine cells from human embryonic stem cells","volume":"24","author":"D\u2019Amour","year":"2006","journal-title":"Nat Biotechnol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of Functional Human Pancreatic \u03b2 Cells In\u00a0Vitro","volume":"159","author":"Pagliuca Felicia","year":"2014","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.12.012","article-title":"Acquisition of Dynamic Function in Human Stem Cell-Derived \u03b2 Cells","volume":"12","author":"Velazco-Cruz","year":"2019","journal-title":"Stem Cell Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.01.040","article-title":"Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control","volume":"10","author":"Robert","year":"2018","journal-title":"Stem Cell Rep"},{"key":"B62","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.1038\/ncomms11463","article-title":"Generation of stem cell-derived \u03b2-cells from patients with type 1 diabetes","volume":"7","author":"Millman","year":"2016","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0271-4","article-title":"Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived beta cells","volume":"21","author":"Nair","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e37004","DOI":"10.1371\/journal.pone.0037004","article-title":"A scalable system for production of functional pancreatic progenitors from human embryonic stem cells","volume":"7","author":"Schulz","year":"2012","journal-title":"PloS One"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2337\/db18-138-OR","article-title":"Initial Clinical Evaluation of VC-01TM Combination Product\u2014A Stem Cell\u2013Derived Islet Replacement for Type 1 Diabetes (T1D)","volume":"67","author":"Henry","year":"2018","journal-title":"Diabetes"},{"key":"B66","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11892-015-0691-5","article-title":"Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity","volume":"15","author":"Burke","year":"2015","journal-title":"Curr Diabetes Rep"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15322","article-title":"Noninvasive diagnosis of recurrent autoimmune type 1 diabetes after islet cell transplantation","volume":"19","author":"Korutla","year":"2019","journal-title":"Am J Transplant"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0187","article-title":"Concise Review: Markers for Assessing Human Stem Cell-Derived Implants as \u03b2-Cell Replacement in Type 1 Diabetes","volume":"5","author":"Pipeleers","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e3283424faa","article-title":"Immunogenicity of embryonic stem cell-derived progenitors after transplantation","volume":"16","author":"English","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-4125-y","article-title":"Immunogenicity of human embryonic stem cell-derived beta cells","volume":"60","author":"van der Torren","year":"2017","journal-title":"Diabetologia"},{"key":"B71","doi-asserted-by":"publisher","first-page":"e04766","DOI":"10.7554\/eLife.04766","article-title":"Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery","volume":"3","author":"Lin","year":"2014","journal-title":"Elife"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0049","article-title":"Targeted Disruption of the \u03b22-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells","volume":"4","author":"Wang","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1902566116","article-title":"Generation of hypoimmunogenic human pluripotent stem cells","volume":"116","author":"Han","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e12616","DOI":"10.15252\/emmm.202012616","article-title":"Improvement of islet transplantation by the fusion of islet cells with functional blood vessels","volume":"13","author":"Nalbach","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1038\/s41598-020-60947-x","article-title":"Pancreatic islets seeded in a novel bioscaffold forms an organoid to rescue insulin production and reverse hyperglycemia in models of type 1 diabetes","volume":"10","author":"Elizondo","year":"2020","journal-title":"Sci Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00219.2014","article-title":"Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts","volume":"307","author":"Motte","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.stemcr.2019.02.002","article-title":"Macroencapsulated Human iPSC-Derived Pancreatic Progenitors Protect against STZ-Induced Hyperglycemia in Mice","volume":"12","author":"Haller","year":"2019","journal-title":"Stem Cell Rep"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0079","article-title":"Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo","volume":"4","author":"Agulnick","year":"2015","journal-title":"Stem Cells Transl Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.636824\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T09:24:46Z","timestamp":1615454686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.636824\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":78,"alternative-id":["10.3389\/fendo.2021.636824"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.636824","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"article-number":"636824"}}